Authors: Delaloge, S Yovine, A Taamma, A Riofrio, M Brain, E Raymond, E Cottu, P Goldwasser, F Jimeno, J Misset, JL Marty, M Cvitkovic, E

Citation: S. Delaloge et al., Ecteinascidin-743: A marine-derived compound in advanced, pretreated sarcoma patients - Preliminary evidence of activity, J CL ONCOL, 19(5), 2001, pp. 1248-1255

Authors: Taamma, A Misset, JL Riofrio, M Guzman, C Brain, E Lazaro, LL Rosing, H Jimeno, JM Cvitkovic, E

Citation: A. Taamma et al., Phase I and pharmacokinetic study of ecteinaseidin-743, a new marine compound, administered as a 24-hour continuous infusion in patients with solid tumors, J CL ONCOL, 19(5), 2001, pp. 1256-1265

Authors: Monnet, I Soulie, P de Cremoux, H Saltiel-Voisin, S Bekradda, M Saltiel, JC Brain, E Dupont-Andre, G Cvitkovic, E

Citation: I. Monnet et al., Phase I/II study of escalating doses of vinorelbine in combination with oxaliplatin in patients with advanced non-small-cell lung cancer, J CL ONCOL, 19(2), 2001, pp. 458-463

Authors: van Kesteren, C Cvitkovic, E Taamma, A Lopez-Lazaro, L Jimeno, JM Guzman, C Mathot, RAA Schellens, JHM Misset, JL Brain, E Hillebrand, MJX Rosing, H Beijnen, JH

Citation: C. Van Kesteren et al., Pharmacokinetics and pharmacodynamics of the novel marine-derived anticancer agent ecteinascidin 743 in a phase I dose-finding study, CLIN CANC R, 6(12), 2000, pp. 4725-4732

Authors: Soulie, P Garrino, C Bensamaine, MA Bekradda, M Brain, E Di Palma, M Goupil, A Misset, JL Cvitkovic, E

Citation: P. Soulie et al., Antitumoral activity of oxaliplatin/cisplatin-based combination therapy incisplatin-refractory germ cell cancer patients, J CANC RES, 125(12), 1999, pp. 707-711